-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

616. Acute Myeloid Leukemias: Investigational Therapies, Excluding Transplantation and Cellular Immunotherapies: Poster III

Symposia: Acute Myeloid Leukemias: Investigational Therapies, Excluding Transplantation and Cellular Immunotherapies Program: Oral and Poster Abstracts
Type: Poster
Monday, December 11, 2023: 6:00 PM-8:00 PM
Halls G-H (San Diego Convention Center)

Andrew A. Lane, MD, PhD1, Jacqueline S. Garcia, MD1, Evangeline G. Raulston1*, Jada L. Garzon1, Ilene Galinsky, ANP1, Emilie W. Baxter1*, Rebecca Leonard1*, Daniel J. DeAngelo2, Marlise R. Luskin, MD3, Christopher R. Reilly, MD4, Maximilian Stahl, MD5, Richard M Stone, MD2, Rahul Vedula, MD1, Martha Wadleigh, MD2, Eric S. Winer, MD2, Tariq Mughal, MD6*, Christopher Brooks6*, Ira V. Gupta, MD6*, Kristen E. Stevenson, MS, PhD7*, Donna S. Neuberg, ScD7, Siyang Ren, MS7*, Marina Y. Konopleva8,9, Anthony Stein, MD10 and Naveen Pemmaraju, MD8

1Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
2Dana-Farber Cancer Institute, Boston, MA
3Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
4Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
5Dana Farber Institute, Boston, MA
6Stemline Therapeutics, New York, NY
7Department of Data Science, Dana-Farber Cancer Institute, Boston, MA
8Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
9Department of Oncology, Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, NY
10City of Hope Cancer Center, Duarte, CA

Naval Daver, MD1, Anthony Selwyn Stein, MD2, Dale Bixby, MD, PhD3*, Wanxing Chai-Ho, MD4, Joshua F. Zeidner, MD5, Keri Maher, DO6, Don A. Stevens, MD7, Maximilian Stahl, MD8, Karen Yee, MD9*, Emily K Curran, MD10, Sawa Ito, MD11, Andrew Sochacki, MD12, David A Sallman, MD13, Robert Hernandez, PhD14*, Simon Metenou, PhD14*, Bo Ma, PhD14*, Kazunobu Kato, MD15 and Amer M. Zeidan, MBBS, MHS16

1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
2City of Hope National Medical Center, Duarte, CA
3University of Michigan Health Systems, Ann Arbor, MI
4Department of Medicine/Division of Hematology and Oncology, University of California, Los Angeles, Los Angeles, CA
5University of North Carolina, Lineberger Comprehensive Cancer Center, Chapel Hill, NC
6Massey Cancer Center, Virginia Commonwealth University, Richmond, VA
7Norton Cancer Institute St. Mathew's, Louisville, KY
8Dana Farber Institute, Boston, MA
9Princess Margaret Cancer Center (PMCC), Toronto, ON, CAN
10University of Cincinnati, Cincinnati, OH
11Hematology and Oncology, Department of Medicine, University of Pittsburgh, Pittsburgh, PA
12START Midwest, Grand Rapids, MI
13H. Lee Moffitt Cancer Center, Tampa, FL
14Shattuck Labs, Durham, NC
15Shattuck Labs, Raleigh, NC
16Department of Internal Medicine, Yale School of Medicine and Yale Cancer Center, Yale University, New Haven, CT

Carissa M. Feliciano1*, Jennifer S. Carew, PhD2, Hetty E. Carraway, MD, MBA3, Justin M. Watts, MD4, Sharad Khurana, MD, MSc5, Bhumika J. Patel, MD6, Keri Maher, DO7, Claudia Espitia2*, Kaijin Wu8*, Denice Tsao-Wie, MS9*, Xuelian Chen8*, Mikkael A. Sekeres, MD10, Stan Louie, PharmD11*, Homa Dadrastoussi, MD8*, Eduardo Fernandez, MD12, Julian Olea, BS8*, Brandon Sookdeo, BA8*, Steffan T. Nawrocki, PhD2*, George Yaghmour, MD9 and Kevin R. Kelly, MD, PhD13

1Keck School of Medicine, University of Southern California, Los Angeles, CA
2Division of Hematology and Oncology, University of Arizona Cancer Center, Tucson, AZ
3Leukemia Program, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
4Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, MIAMI, FL
5University of Arizona Cancer Center, Tucson, AZ
6Hematology Oncology Program, Prisma Health, Greenville
7Massey Cancer Center, Virginia Commonwealth University, Tucson, AZ
8Division of Hematology, Keck School of Medicine, University of Southern California, Los Angeles, CA
9Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA
10Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL
11Mann School of Pharmacy and Pharmaceutical Sciences, University of Southern California, Los Angeles, CA
12USC Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA
13Division of Hematology, Keck School of Medicine, University of Southern California, Los Angeles

Huafeng Wang1*, Qike Zhang2*, Qingliang Teng3*, Zhenyu Li4*, Hong Liu, MD5*, Zhongmin Maxwell Wang6*, Baiyong Li6*, Yu Xia6* and Jie Jin1

1The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China
2Gansu Provincial Hospital, Lanzhou, China
3Taian City Central Hospital, Taian, China
4The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China
5Affiliated Hospital of Nantong University, Nantong, China
6Akeso Biopharma Inc., Zhongshan, China

Jie Jin1, Huafeng Wang1*, Wen-Juan Yu1*, Zheng Ge2, Xudong Wei3*, Yuhua Li4*, Zhongxing Jiang, MD5*, Yiqing Li6*, Xin Du7*, Linhua Yang, MD8*, Lie Lin, MD9*, Jishi Wang, PhD10, Yazhou Yao11*, Xiaoping Hu12*, Jianping Lan13*, Xiuzhi Deng14*, Tong Chen15, Xianqi Feng16*, Dengju Li17*, Ming Hou18*, Rong Fu19*, Siyong Huang20*, Jingbo Wang21*, Xin Du, MD22*, Hui Yang23*, Haiping Yang24*, Yingzhi Jiang25*, Zhijie Wang25*, Deng Li25*, Bing Liu25*, Ning Kang25*, Yulei Zhuang25* and Yingjun Zhang25*

1The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
2Zhongda Hospital, Southeast University, Nanjing, China
3Department of Hematology, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China
4Department of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou, China
5The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
6Sun Yat-sen Memorial Hospital of Sun Yat-sen University, Guangzhou, China
7Guangdong Provincial People's Hospital, Guangzhou, China
8The Second Hospital of Shanxi Medical University, Taiyuan, China
9Hainan General Hospital, Haikou, China
10Department of Hematology, Affiliated Hospital of Guizhou Medical University, Guiyang City, China
11Baoji Central Hospital, Baoji, China
12PKU Care Luzhong Hospital, Zibo, China
13Department of Hematology, Zhejiang Provincial People’s Hospital, Hangzhou, China
14Weihai Municipal Hospital, Weihai, China
15Department of Hematology, Huashan Hospital, Fudan University, Shanghai, China
16Affiliated Hospital of Qingdao University, qingdao, China
17Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science & Technology, Wuhan, China
18Qilu Hospital of Shandong University, Jinan, China
19Tianjin Medical University General Hospital, Tianjin, China
20Xi'an Gaoxin Hospital, Xi'an, China
21Aerospace Center Hospital, Beijing, China
22Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University, Shenzhen, China
23Shunde Hospital of Southern Medical University, Foshan, China
24The First Affiliated Hospital of Henan University of Science and Technology, Luoyang, China
25Sunshine Lake Pharma Co., Ltd, Dongguan, China

Jayastu Senapati, MD, MBBS, DM1, Sanam Loghavi, MD2, Patrick K Reville, MD, MPH1, Naval Daver, MD1, Gautam Borthakur, MD1, Courtney D. DiNardo, MD, MSc1, Elias Jabbour3, Nicholas J. Short, MD1, Naveen Pemmaraju, MD1, Abhishek Maiti, MD4, Ghayas C. Issa5, Uday R. Popat, MD6, Amin Alousi6*, Elizabeth J. Shpall, MD6, Koji Sasaki, MD7, Guillermo Garcia-Manero, MD8, Farhad Ravandi, MD, MBBS1 and Tapan M. Kadia, MD1

1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
2Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
3University of Texas M.D. Anderson Cancer Ctr., Houston, TX
4Department of Leukemia, MD Anderson Cancer Center, Houston, TX
5The University of Texas MD Anderson Cancer Center, Houston, TX
6Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
7Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
8University of Texas MD Anderson Cancer Center, Houston, TX

Sung-Soo Yoon, MD, PhD1, Dongyeop Shin2*, Je-Hwan Lee, MD, PhD3, Jun Ho Jang, MD, PhD4, June-Won Cheong5, Ho-Jin Shin, MD6*, Jeong-Ok Lee, MD7, Yoo Jin Lee, DR8*, Joseph Clarey, DR9*, Gi-Jun Sung, PhD10*, Kyung-Ah Kim10*, Ky-Youb Nam, PhD11*, Kyu-Tae Kim, PhD10*, June Han, PhD10*, JeongHyeok Yoon, PhD10*, Bao Nguyen12*, Li Li, MD13* and Donald Small, MD, PhD12

1Seoul National University Hospital, Seoul, South Korea
2Division of Hematology/Medical Oncology, Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea, Republic of (South)
3Department of Hematology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of (South)
4Division of Hematology-Oncology, Department of Internal Medicine, Samsung Medical Center, Seoul, Korea, Republic of (South)
5Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea, Republic of (South)
6Department of Internal Medicine, Pusan National University Hospital, Busan, Korea, Republic of (South)
7Department of Internal Medicine, Seoul National Univ. Bundang Hospital, Seongnam-Si, None, KOR
8Division of Hemato-oncology, Department of Internal Medicine, Ulsan University Hospital, Uisan, KOR
9ICON cancer centre, North Mackay, Australia
10Pharos iBio Co., Ltd., Anyang, Korea, Republic of (South)
11Pharos iBio Co., Ltd., Anyang, South Korea
12Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD
13Johns Hopkins Univ. School of Med., Baltimore, MD

Courtney D. DiNardo, MD, MSc1, Michael R. Savona, MD2, Ashwin Kishtagari, MBBS2, Amir T. Fathi, MD3, Kapil N. Bhalla, MD1, Samuel Agresta, MD4*, Sarah Reilly4*, Caroline Almon4*, Murphy Hentemann4*, Denice Hickman4*, Dillon Corrigan4*, Meghan Macaraeg4*, Jessica Piel, PhD, BA4*, Kim Horrigan4*, Salah Nabhan4*, Paul Martin5* and Eytan M. Stein6

1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
2Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN
3Massachusetts General Hospital Cancer Center, Boston, MA
4Foghorn Therapeutics Inc., Cambridge, MA
5Certara Integrated Drug Development, Princeton, NJ
6Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY

David Taussig, PhD, MRCP, FRCPath1, David C. de Leeuw, MD, PhD2*, Mojca Jongen-Lavrencic, MD, PhD3, Jenny O'Nions, MBBCh, PhD, MRCP, FRCPath4*, Thinzar Koko, MRCP, MRCPath5, Emma Searle, MD6*, Hendrik-Tobias Arkenau, MD, PhD, FRCP7*, Sue Brook, PhD, MRCP, FFPM7*, Charlotte Burmester, MSc7*, Geoff Fisher, PhD7*, Katie Stoddart, BSc7* and Peter Tan, MBBS (Hons), Mphil, FRACP, FRCPA8*

1The Royal Marsden Hospital and Institute of Cancer Research, London, United Kingdom
2Amsterdam University Medical Centres, location VUMC, Amsterdam, Netherlands
3Erasmus University Medical Center, Rotterdam, Netherlands
4University College London NHS Foundation Trust, London, United Kingdom
5Royal Marsden Hospital and Institute of Cancer Research, London, United Kingdom
6The Christie NHS Foundation Trust and University of Manchester, Manchester, United Kingdom
7Ellipses Pharma, London, United Kingdom
8Royal Perth Hospital, Perth, Australia

Matthew S. Davids, MD, MMSc1, Yesid Alvarado Valero, MD2, Catherine Diefenbach, MD3*, Daniel N. Egan, MD4, Shira N. Dinner, MD5, Monzr M. Al Malki, MD6, Kebede Begna, MD7, Avyakta Kallam, MBBS8, Sameem Abedin, MD9, Rachel J. Cook, MD10, Nathalie Javidi-Sharifi, MD11, Edward Dominguez12*, Lu Miao, PhD13*, Richard G Ghalie, MD, MBA13 and Alexey Danilov, MD14

1Department of Medical Oncology, Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA
2Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
3NYU School of Medicine, New York, NY
4Swedish Center for Blood Disorders and Stem Cell Transplants, Seattle, WA
5Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL
6National Medical Center, City of Hope, Duarte, CA
7Division of Hematology, Mayo Clinic, Rochester, MN
8University of Nebraska Medical Center, Omaha, NE
9Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI
10Oregon Health and Science University, Portland, OR
11Dana-Farber Cancer Institute, Boston
12Lymphoma Department, City of Hope, Duarte, CA
13MEI Pharma, San Diego, CA
14Department of Hematology and HCT, City of Hope National Medical Center, La Canada Flintridge, CA

Sonja Loges, MD, PhD1,2*, Michael Heuser3*, Jolanta Chromik4*, Grerk Sutamtewagul, MD5, Silke Kapp-Schwoerer, MD6*, Monica Crugnola, MD7*, Nicola Di Renzo, MD8*, Roberto Massimo Lemoli, MD9*, Daniele Giovanni Mattei, MD10, Isabel Ben Batalla, PhD11*, Jonas Waizenegger, MD12*, Melanie Janning, MD13*, Lisa-Marie Rieckmann, MSc14*, Charles Imbusch15*, Niklas Beumer, MSc14*, David Micklam16*, Claudia Gorcea-Carson, MD17*, Cristina Oliva, MD17*, Walter Fiedler, MD12, Yesid Alvarado-Valero, MD18*, Nigel McCracken, PhD17* and Bjorn T. Gjertsen, MD, PhD19

1DKFZ-Hector Cancer Institute, Department of Personalised Oncology, Heidelberg, Baden-Württemberg, DEU
2Department of Personalised Oncology, Mannheim, Baden-Württemberg, DEU
3Hannover Medical School, Hannover, Germany, Hannover, DEU
4University Hospital frankfurt, Bielsko-białA, POL
5University of Iowa Hospitals and Clinics, Iowa City, IA
6University Hospital of Ulm, Ulm, Germany
7Hematology Unit and BMT Center Azienda Ospedaliero Universitaria Parma, Parma, Italy
8Haematology, Ospedale V. Fazzi, Lecce, Italy, Lecce, Italy
9Clinic of hematology, Department of Internal medicine (DiMI), University of Genoa, Genoa, Italy
10ASO S. Croce e Carle, Cuneo, Italy
11DKFZ-Hector Cancer Instiute, University Medical Centre Mannheim, Hamburg, DEU
12University Hospital Hamburg-Eppendorf, Hamburg, DEU
13Department of Personalized Oncology, DKFZ-Hector Cancer Institute, University Medical Center Mannheim, Mannheim, Germany, Mannheim, DEU
14Department of Personalized Oncology, German Cancer Research Center (DKFZ), Heidelberg, Heidelberg, Germany
153Department of Personalized Oncology, German Cancer Research Center (DKFZ), Heidelberg, Heidelberg, Germany
16Translational research, BerGenBio ASA, Bergen, Norway
17BerGenBio Ltd, Oxford, United Kingdom
18The University of Texas M.D. Anderson Cancer Center, Houston, TX
19Center for Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, Bergen, Norway

Feifei Tang1*, Wen-Bing Duan2*, Xiao-Hong Liu2*, Sheng-Ye Lu2*, Xiao-Su Zhao2*, Ya-Zhen Qin, MD2*, Jin-Song Jia, MD, PhD3*, Jing Wang, MD2*, Li-Zhong Gong2*, Qian Jiang, MD2, Zhao Ting2*, Hong-Xia Shi, MD2*, Ying-Jun Chang2*, Xiao-Jun Huang2,4 and Hao Jiang2*

1Peking University People’s Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, AL, China
2Peking University People’s Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China
3Peking University People’s Hospital, Peking University Institute of Hematology, Beijing, China
4Peking-Tsinghua Center for Life Sciences, Academy for Advanced Interdisciplinary Studies, Peking University, Beijing, China

Abhishek Maiti, MD1, Courtney D. DiNardo, MD, MSc1, Maro Ohanian, DO1*, Naval Daver, MD1, Gautam Borthakur, MD1, Kelly S. Chien, MD1, Ghayas C. Issa2, Koichi Takahashi, MD, PhD1, Lucia Masarova, MD1, Yesid Alvarado Valero, MD1, Elias Jabbour3, William G. Wierda, MD, PhD2, Nicholas J. Short, MD1, Melissa MacFarland4*, Allison Pike, RN1*, Tapan M. Kadia, MD1, Farhad Ravandi, MD, MBBS1, Hagop M. Kantarjian, MD1, Guillermo Garcia-Manero, MD5 and Marina Y. Konopleva, MD, PhD1,6*

1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
2The University of Texas MD Anderson Cancer Center, Houston, TX
3University of Texas M.D. Anderson Cancer Ctr., Houston, TX
4University of Texas MD Anderson Cancer Center, Houston
5University of Texas MD Anderson Cancer Center, Houston, TX
6Cancer Center, Albert Einstein College of Medicine, New York, NY

Sylvain Garciaz1*, Pierre Bories, MD, PhD2*, Jean-Marie Boher3*, Marie Anne Hospital, MD, PhD4*, Christian Récher, MD5*, Colombe Saillard, MD4*, Yosr Hicheri4*, Coralie Belanger, MD6*, Renato Monteiro6*, Olivier Hermine, MD, PhD7, Pierre Launay, PhD6* and Norbert Vey, MD8

1Hematology Department, Integrative Structural and Chemical Biology, Aix-Marseille Université, Inserm, CNRS, Institut Paoli-Calmettes, Centre de Recherche en Cancérologie de Marseille, Marseille, France
2Early Phase Unit, University Cancer Institute Toulouse Oncopole, Toulouse, France
3Institut Paoli Calmettes, Biostatistics Unit, Marseille, France
4Department of Hematology, Institut Paoli-Calmettes, Marseille, France
5Service d'Hématologie, Centre Hospitalo-universitaire de Toulouse, Centre de Recherches en Cancérologie de Toulouse, Institut Universitaire du Cancer de Toulouse-Oncopole, Université de Toulouse, UPS, INSERM, CNRS, Toulouse, France, Toulouse, France
6Inatherys, Evry, France
7Department of Hematology, Hospital Necker, Assistance Publique Hôpitaux de Paris, University Paris Descartes, Paris, France
8Aix-Marseille University, INSERM U1068, CNRS, Institut Paoli-Calmettes, CRCM, Marseille, France

Xiaoqin Feng1*, Chunfu Li, PhD2, Jian Li3*, Yongzhi Zheng4*, Mincui Zheng5*, Huirong Mai6*, Lihua Yang, MD7*, Xiangling He8*, Yingyi He, MD, PhD9*, Hong Wen10* and Yirong Li11*

1Department of Pediatrics, Nanfang Hospital, Guangzhou, China
2Nanfang-Chunfu Children's Institute of Hematology & Oncology, Taixin Hospital, Dongguan, Guangdong, China
3Pediatrics, Fujian Medical University Union Hospital, Fuzhou, China
4Fujian Institute of Hematology, Fujian Provincial Key Laboratory of Hematology, Fujian Medical University Union Hospital, Fuzhou, China
5Department of Hematology, Hunan Children's Hospital, Changsha, China
6Hematology and Oncology, Shenzhen Children's Hospital, Shenzhen, China
7Pediatric Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou, CHN
8Hunan Provincial People's Hospital, Changsha, CHN
9Guangzhou Women and Children's Medical Center, Guangzhou, CHN
10The First Affiliated Hospital of Xiamen University, Xiamen, CHN
11Pediatrics, Nanfang Hospital, Guangzhou, China

Ivetta Danylesko1,2*, Avichai Shimoni, MD2,3*, Abraham Avigdor, MD4,5, Meirav Kedmi, MD2*, Noga Shem-Tov, MD2,4*, Ronit Yerushalmi, MD2,4, Maya Sasson6*, Dan Dominissini7*, Borje S. Andersson, MD8 and Arnon Nagler, MD9,10

1Division of Hematology, Sheba Medical Center, Tel Hashomer, AL, ISR
2Tel-Aviv University and Sackler School of Medicine, Tel-Aviv, Israel
3The Division of Hematology and Bone Marrow Transplantation, Sheba Medical Center, Ramat Gan, Israel
4Division of Hematology and Bone Marrow Transplantation, The Chaim Sheba Medical Center, Ramat Gan, Israel
5Faculty of Medicine, Tel Aviv University, Tel Aviv, Tel Aviv, Israel
6The genomics Unit, Sheba Cancer Research Center and Wohl Institute of Translational Medicine, Sheba Medical Center, Tel Hashomer, Israel
7The genomics Unit, Sheba Cancer Research Center and Wohl Institute of Translational Medicine, Sheba Medical Center,, Tel Hashomer, Israel
8Department of Stem Cell Transplantation & Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston
9Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel Hashomer, Israel
10Tel-Aviv University School of Medicine, Tel-Aviv, Israel

Ritul Sharma1*, Melanie M Frigault, PhD2*, Amy J Johnson, PhD2, Raquel Izumi, PhD2, Ahmed Hamdy, MD2, Joseph Birkett, PhD3*, Beatrix Stelte-Ludwig, PhD4*, Luke Maese, DO5, Norman J. Lacayo, MD6* and Aru Narendran, MD, PhD1*

1University of Calgary, Calgary, AB, Canada
2Vincerx Pharma, Palo Alto, CA
3Vincerx Pharma, Palo Alto
4Vincerx Pharma GmbH, Monheim, Germany
5University of Utah, Primary Children’s Hospital, Salt Lake City, UT
6Bass Center for Childhood Cancer and Blood Disorders, Department of Pediatrics, Stanford University, Stanford, CA

Brian A. Jonas, MD, PhD1, Karen Yee, MD2*, Alice Mims, MD3, Paul B. Koller, MD4, Joseph Brandwein, MD5, Gail J. Roboz, MD6, Glenn Michelson, MD7, Linh Nguyen, PhD7*, Mark R Bray, PhD8*, Emily Roberts-Thomson7*, Roger Sidhu, MD7* and Gautam Borthakur, MD9

1Department of Internal Medicine, Division of Malignant Hematology, Cellular Therapy and Transplantation, University of California Davis School of Medicine, Sacramento, CA
2Princess Margaret Cancer Center (PMCC), Toronto, ON, CAN
3Division of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, OH
4Hematology/HCT, City of Hope National Medical Center, Duarte, CA
5University of Alberta Hospital, Edmonton, AB, Canada
6Weill Cornell Medicine and The New York Presbyterian Hospital, New York, NY
7Treadwell Therapeutics Inc, San Mateo, CA
8Treadwell Therapeutics Canada Inc, Toronto
9Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX

Robin Williams, MD, MS1, Lane Miller, MD, MSc2*, Stephanie Massaro, MD, MPH3*, Elizabeth Krieger, MD4*, Melinda Pauly, MD5, Catherine Nelson, DO, MS6*, Rebecca Johnson, MD7*, Jennifer J.G. Welch, MD8, Deepa Bhojwani, MD9, Babak Moghimi, MD10*, Philip Neff, MD11*, Terzah M. Horton, MD, PhD12*, Hamayun Imran, MBBS, MD13, Raul C. Ribeiro, MD14, Terri L. Guinipero, MD15*, Matthew A. Kutny, MD16, Felipe Bautista, MD17*, Amy Johnson, MD18*, Karen Lewing, MD19*, Alan S Gamis, MD, MPH20, Julienne Brackett, MD, MS12, David McCall, MD21*, Teena Bhatla, MD22, Maria Luisa Sulis, MD23, Amy Tellinghuisen, MD24*, Jill C. Beck, MD25* and Soheil Meshinchi, MD, PhD26

1University of Minnesota Masonic Children’s Hospital, Minneapolis, MN
2Children’s Minnesota, Minneapolis, MN
3Yale, New Haven, CT
4VCU, Richmond, VA
5Children’s Healthcare of Atlanta, Atlanta, GA
6Sanford Health, Sioux Falls, SD
7Mary Bridge Children’s Hospital, Tacoma, WA
8Hasbro Children’s Hospital (Lifespan), Providence, RI
9Hematology/Oncology, Children's Hospital of Los Angeles, Los Angeles, CA
10Children’s Hospital Los Angeles, Los Angeles, CA
11Dell Children’s Hospital, Austin, TX
12Baylor, Houston, TX
13USA Pediatric Hematology Oncology, University of South Alabama (USA Health), Mobile, AL
14Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN
15Division of Hematology/Oncology/BMT, Nationwide Children's Hospital, Columbus, OH
16University of Alabama Birmingham, Birmingham, AL
17Novant Health Hemby Children’s Hospital, Charlotte, NC
18Children’s Mercy Kansas City, Kansas City, MO
19Children's Mercy Kansas City, Kansas City, MO
20Hematology/Oncology/BMT, Children's Mercy Kansas City, Kansas City, MO
21Division of Pediatrics, MD Anderson, Houston, TX
22Newark Beth Israel Medical Center, Newark, NJ
23Memorial Sloan Kettering Cancer Center, New York, NY
24Seattle Children’s Hospital, Seattle, WA
25Children's Hospital & Medical Center Omaha, Omaha, NE
26Translational Sciences and Therapeutics, Fred Hutchinson Cancer Research Center, Seattle, WA

*signifies non-member of ASH